Crossmark

Survival time prediction in patients with high-grade serous ovarian cancer based on 18F-FDG PET/CT- derived inter-tumor heterogeneity metrics

Published Online: 2024-03-12

Authors

He, Dianning

Zhang, Xin

Chang, Zhihui

Liu, Zhaoyu

Li, Beibei http://orcid.org/0009-0007-2566-7476
License Information

Text and Data Mining valid from 2024-03-12

Version of Record valid from 2024-03-12
More Information

Article History

Received: 6 November 2023

Accepted: 5 March 2024

First Online: 12 March 2024

Declarations

:

: The study was approved by Ethics Committee of Shengjing hospital of China Medical University (No. 2021PS881K). The requirement for informed consent was waived by the Ethics Committee of Shengjing hospital of China Medical University because of the retrospective nature of the study.

: Not applicable.

: The authors declare no competing interests.

Document is current